World's Best Scientists 2026 revealed!
Award Badge
Medicine
Australia
2023

D-Index & Metrics

Medicine

D-Index
133
Citations
65573
World Ranking
2230
National Ranking
66

Research.com Recognitions

  • 2023 - Research.com Medicine in Australia Leader Award

Overview

Murray D. Esler is affiliated with the Baker IDI Heart and Diabetes Institute in Australia and has made substantial contributions in the field of medicine, particularly in cardiology and cardiovascular medicine. Their research output includes 121 publications across various subfields such as cardiology and cardiovascular medicine, surgery, endocrinology, diabetes and metabolism, pharmacology, and nephrology.

Their most frequently addressed topics include:

  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Syncope and Autonomic Disorders
  • Hormonal Regulation and Hypertension
  • Cardiac Health and Mental Health
  • Non-Invasive Vital Sign Monitoring
  • Cardiovascular Health and Disease Prevention

Murray D. Esler has published extensively with notable frequency in the following journals and venues:

  • Journal of Hypertension (10 publications)
  • Hypertension (6 publications)
  • Clinical Autonomic Research (3 publications)
  • The Lancet (2 publications)
  • Hypertension Research (2 publications)

Some of the recently published papers including first or contributing authorship under their name are:

  • "Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?" (2020, Journal of Hypertension)
  • "Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial" (2022, The Lancet)
  • "Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial" (2022, The Lancet)
  • "Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension" (2023, Hypertension)
  • "Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines" (2022, Hypertension)

Frequent collaborators in their research include the following co-authors:

  • Élisabeth Lambert
  • Markus P. Schlaich
  • Gavin Lambert
  • Roland E. Schmieder
  • David E. Kandzari

Best Publications

  • Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial

    Murray D. Esler;Henry Krum;Paul A. Sobotka;Markus P. Schlaich

  • Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

    Henry Krum;Markus Schlaich;Robert Whitbourn;Paul Sobotka

  • Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.

    Gregory J. Hasking;Murray D. Esler;Garry L. Jennings;Deborah Burton

  • Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension

    Markus P. Schlaich;Paul A. Sobotka;Henry Krum;Elisabeth Lambert

  • Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions

    M Esler;G Jennings;G Lambert;I Meredith

  • Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension A Pilot Study

    Felix Mahfoud;Markus Schlaich;Ingrid Kindermann;Christian Ukena

  • Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover.

    M Esler;G Jennings;P Korner;I Willett

  • "Stress" and coronary heart disease: psychosocial risk factors.

    Stephen J Bunker;David M Colquhoun;Murray D Esler;Ian B Hickie

  • Adverse consequences of high sympathetic nervous activity in the failing human heart

    David M. Kaye;Jeffrey Lefkovits;Garry L. Jennings;Peter Bergin

  • Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.

    Markus P. Schlaich;Elisabeth Lambert;David M. Kaye;Zygmunt Krozowski

  • Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study

    Henry Krum;Markus P Schlaich;Paul A Sobotka;Michael Böhm

  • The human sympathetic nervous system: its relevance in hypertension and heart failure

    Gianfranco Parati;Murray Esler

  • Mild high-renin essential hypertension. Neurogenic human hypertension?

    Murray Esler;Stevo Julius;Andrew Zweifler;Otelio Randall

  • The sympathetic system and hypertension.

    Murray Esler

  • Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy

    Markus P. Schlaich;David M. Kaye;Elisabeth Lambert;Marcus Sommerville

  • The Sympathetic Nervous System Alterations in Human Hypertension

    Guido Grassi;Allyn Mark;Murray Esler

  • Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial

    Murray D Esler;Henry Krum;Markus Peter Schlaich;Roland E Schmieder

  • Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.

    David E Kandzari;Deepak L Bhatt;Sandeep Kaur Brar;Chandan M Devireddy

  • Translational medicine: the antihypertensive effect of renal denervation

    Gerald F. DiBona;Murray David Esler

  • How to assess sympathetic activity in humans.

    Guido Grassi;Murray Esler

Frequent Co-Authors

Markus P. Schlaich
Markus P. Schlaich University of Western Australia
Gavin W. Lambert
Gavin W. Lambert Swinburne University of Technology
Garry L. Jennings
Garry L. Jennings University of Sydney
David M. Kaye
David M. Kaye The Alfred Hospital
Henry Krum
Henry Krum Monash University
Helen Cox
Helen Cox University of Cape Town
Michael Böhm
Michael Böhm Saarland University
Anthony M. Dart
Anthony M. Dart Monash University
Paul J. Nestel
Paul J. Nestel Baker IDI Heart and Diabetes Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine offers numerous career options, with many professionals choosing to expand their skills or pivot to related fields. For those interested in the administrative side of healthcare, pursuing a health care administration degree online can open doors to leadership roles in hospitals and clinics.

Many students look for flexible and budget-friendly programs, such as the cheapest mha programs online. An MHA is ideal for those seeking advanced expertise in healthcare management and policy.

Aspiring nurses can take the next step in their careers with the cheapest dnp program. A Doctor of Nursing Practice degree focuses on clinical leadership and evidence-based patient care.

For those considering pharmacy, an online pharmd provides a flexible path to becoming a pharmacist while balancing work and study.

These related pathways offer diverse options for advancing your healthcare career, and online programs make it easier than ever to pursue them alongside other commitments.

Best Scientists Citing Murray D. Esler

Trending Scientists

Recently Published Articles